PT Abadi Lestari Indonesia Tbk (RLCO) has recorded double-digit net\nprofit growth in the first half of 2026 amidst market dynamics. As of 30\nJune 2026, the company reported net profit attributable to the owners of\nthe parent entity of Rp 20.36 billion, an increase of 13.39% compared to\nRp 17.96 billion during the same period the previous year.<\/p>\n
The President Director of PT Abadi Lestari Indonesia Tbk, Edwin\nPranata, stated that this achievement reflects the company\u2019s ability to\nmaintain business performance, strengthen financial fundamentals, and\ncontinue sustainable business development. He expressed gratitude for\nclosing the first semester of 2026 with positive performance, noting\nthat this serves as motivation to enhance competitiveness through\noperational quality, product innovation, and healthy business\nmanagement.<\/p>\n
Throughout the first half of 2026, the company recorded sales of Rp\n272 billion, with processed edible bird\u2019s nest products remaining the\nprimary revenue contributor. Sales of processed edible bird\u2019s nest\nproducts were recorded at Rp 234.3 billion, or approximately 86.2% of\ntotal sales, while consumer products contributed Rp 37.6 billion, or\nabout 13.8%.<\/p>\n
In line with increased business activity, the cost of goods sold was\nrecorded at Rp 210.9 billion, resulting in a gross profit of Rp 61.09\nbillion. Regarding its financial position, the company\u2019s total assets\nincreased by 3.22% to Rp 835.8 billion as of 30 June 2026, compared to\nRp 809.7 billion on 31 December 2025, primarily driven by an increase in\ncurrent assets to Rp 730.28 billion.<\/p>\n
Total liabilities were recorded at Rp 510.1 billion, a slight\nincrease from the end of 2025. Conversely, long-term liabilities\ndecreased to Rp 21.3 billion from the previous Rp 27.6 billion, while\ntotal equity increased by 6.67% to Rp 325.7 billion, supported by the\ncurrent period\u2019s profit. From a liquidity perspective, cash receipts\nfrom customers increased to Rp 221.9 billion compared to Rp 200.1\nbillion in the first half of 2025. Investment activities during the\nperiod focused on supporting business development, including investments\nin intangible assets. As of 30 June 2026, intangible assets under\ndevelopment largely consist of the bioactive testing development for\nphytopharmaceutical products, which is approximately 32% financially\ncomplete and expected to be finished in 2027. With prudent financial\nmanagement, the company closed the first half of 2026 with cash and cash\nequivalents of Rp 65.7 billion, which remains adequate to support\noperational needs and business expansion.<\/p>", "url": "https:\/\/jawawa.id\/newsitem\/rlco-profits-grow-by-double-digits-1785649870", "image": "" }, "sponsor": "Okusi Associates", "sponsor_url": "https:\/\/okusiassociates.com" }